| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Milestone Pharmaceuticals Inc. | Chief Commercial Officer | Common Shares | 175K | $240K | $1.37 | Jul 11, 2025 | Direct |
| Milestone Pharmaceuticals Inc. | Chief Commercial Officer | Employee Stock Option (right to buy) | 121K | Jan 27, 2025 | Direct | ||
| Milestone Pharmaceuticals Inc. | Chief Commercial Officer | Restricted Stock Unit | 80.4K | Jan 27, 2025 | Direct | ||
| Milestone Pharmaceuticals Inc. | Chief Commercial Officer | Series A Common Warrants (right to buy) | 66.7K | Jul 11, 2025 | Direct | ||
| Milestone Pharmaceuticals Inc. | Chief Commercial Officer | Series B Common Warrants (right to buy) | 66.7K | Jul 11, 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| MIST | Milestone Pharmaceuticals Inc. | Jul 11, 2025 | 3 | $0 | 4 | Jul 15, 2025 | Chief Commercial Officer |
| MIST | Milestone Pharmaceuticals Inc. | Jan 27, 2025 | 2 | $0 | 4 | Jan 29, 2025 | Chief Commercial Officer |
| MIST | Milestone Pharmaceuticals Inc. | Feb 16, 2023 | 1 | $0 | 4 | Feb 17, 2023 | Chief Commercial Officer |
| MIST | Milestone Pharmaceuticals Inc. | Mar 21, 2022 | 1 | $0 | 4 | Mar 23, 2022 | Chief Commercial Officer |